Description

n-Cyclohexyl-4,5,6,7-tetrahydrothieno[3,2-c]pyridine-2-carboxamide HBr is a high-purity, advanced pharmaceutical intermediate designed for research and development. This compound is critical for medicinal chemists seeking to develop novel therapeutic agents, particularly within the central nervous system and cardiovascular domains. It is primarily utilized by pharmaceutical R&D laboratories, academic research institutions, and CDMOs (Contract Development and Manufacturing Organizations) engaged in innovative drug discovery programs.

Application

• Pharmaceutical Intermediate: Serves as a key building block in the synthesis of novel active pharmaceutical ingredients (APIs) targeting specific biological pathways.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and lead optimization for new drug candidates.
• Neurological Disorder Research: Investigated for potential applications in developing treatments for conditions related to neurotransmitter modulation.
• Cardiovascular Drug Development: Explored as a precursor for compounds with potential vasodilatory or antiplatelet activity.
• Chemical Biology Probes: Utilized in the creation of specialized molecular probes to study enzyme function and receptor interactions.
• Process Chemistry Scale-up: Supplied to CDMOs for process development and pilot-scale synthesis of experimental therapeutics.

Basic Information

Product Name	n-Cyclohexyl-4,5,6,7-tetrahydrothieno[3,2-c]pyridine-2-carboxamide HBr
CAS No.	2304583-92-2
Molecular Formula	C18H25N2OS • HBr
Molecular Weight	397.38 g/mol
Synonyms	n-Cyclohexyl-4,5,6,7-tetrahydrothieno[3,2-c]pyridine-2-carboxamide hydrobromide; Cyclohexyl-tetrahydrothienopyridine-carboxamide HBr; 2304583-92-2; Thienopyridine carboxamide derivative HBr salt; n-Cyclohexyl-4,5,6,7-tetrahydrothieno[3,2-c]pyridine-2-carboxylic acid amide hydrobromide; 2-Carboxamide, n-cyclohexyl-4,5,6,7-tetrahydrothieno[3,2-c]pyridine, hydrobromide
EINECS	Contact for details

Quality Control

Our n-Cyclohexyl-4,5,6,7-tetrahydrothieno[3,2-c]pyridine-2-carboxamide HBr is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the stringent requirements of pharmaceutical R&D. A comprehensive Certificate of Analysis (COA) detailing purity, impurities, and other critical parameters is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed in a dry environment to prevent moisture absorption, which can affect stability and handling properties.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 98.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm
Related Substances (HPLC)	Total impurities ≤ 2.0%; Any single impurity ≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.